Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions
NCT01331421
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
exemestane
Sponsor
Roxane Laboratories